The treatment of peripheral T-cell lymphomas is challenging, as they often display a severe prognosis and lack effective treatment strategies. We will try to answer three burning questions: can we differentiate the initial treatment based on the histotype and the clinical presentation of peripheral T-cell lymphoma patients? Do we require an autologous stem cell transplantation in all patients? Is there room for improvement in the setting of relapsed and refractory disease? © 2023 John Wiley & Sons Ltd.
Alessandro Broccoli, Pier Luigi Zinzani. Peripheral T-cell lymphomas. Hematological oncology. 2023 Jun;41 Suppl 1:82-87
PMID: 37294962
View Full Text